Skip to main content
Equibles

Woodline Partners LP

Position in GPCR — Structure Therapeutics Inc.

CIK 1784547 San Francisco, CA
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,254,875
-$942,070 QoQ
Shares Held
153,808
-19.4% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#43
of 190 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. GPCR ranks #107 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in GPCR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,254,875 153,808
2026-03-31 $9,196,945 190,808
2025-12-31 $8,617,384 123,902
2025-09-30 $1,832,320 65,440
2025-06-30 $3,659,635 176,453
2025-03-31 $3,036,589 175,424
2024-12-31 $9,055,395 333,901
2024-09-30 $14,552,738 331,573
2024-06-30 $13,249,737 337,401
2024-03-31 $7,710,171 179,892
2023-12-31 $7,304,966 179,219
2023-09-30 $8,571,400 170,000
2023-06-30 $7,066,900 170,000
2023-03-31 $4,044,300 170,000